Myeloperoxidase antineutrophil cytoplasmic antibody positive vasculitis during propylthiouracil treatment: Successful management with oral corticosteroids

Pediatrics International

Volumn 42, Issue 2, 2000, Pages 170-173

  Matsubara, Kousaku ^a   Nigami, Hiroyuki ^a   Harigaya, Hidekazu ^a   Osaki, Masaki ^a   Baba, Kunizo ^a  

^a NISHI KOBE MEDICAL CENTER   (Japan)

Author keywords

Antineutrophil cytoplasmic auto antibody; Corticosteroids; Propylthiouracil; Side effect; Vasculitis

Indexed keywords

CORTICOSTEROID; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; PROPYLTHIOURACIL; THIAMAZOLE;

ADOLESCENT; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; DISEASE COURSE; DRUG INDUCED DISEASE; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; PRIORITY JOURNAL; THYROID DISEASE; VASCULITIS;

ADMINISTRATION, ORAL; ADOLESCENT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTITHYROID AGENTS; FEMALE; GLUCOCORTICOIDS; HUMANS; PEROXIDASE; PREDNISOLONE; PROPYLTHIOURACIL; VASCULITIS;

EID: 0034111729     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-200X.2000.01185.x     Document Type: Article

References (10)

1. 1 Cid MC. New developments in the pathogenesis of systemic vasculitis. Curr. Opin. Rheumatol. 1996; 8: 1-11.
2. 2 Dolman KM, Gans ROB, Vervaat TJ et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 1993; 342: 651-2.
3. 3 Vogt BA, Kim Y, Jennette JC, Falk RJ, Burke BA, Sinaiko A. Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis as a complication of treatment with propylthiouracil in children. J. Pediatr. 1994; 124: 986-8.
4. 4 Tanemoto M, Miyakawa H, Hanai J, Yago M, Kitaoka M, Uchida S. Myeloperoxidase-antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis complicating the course of Graves' disease: Report of three adult cases. Am. J. Kidney Dis. 1995; 26: 774-80.
5. 5 Kitahara T, Hiromura K, Maezawa A et al. Case of propylthiouracil-induced vasculitis associated with antineutrophil cytoplasmic antibody; review of literature. Clin. Nephrol. 1997; 47: 336-40.
6. 6 Fujieda M, Nagata M, Akioka Y, Hattori M, Kawaguchi H, Ito K. Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with propylthiouracil therapy. Acta Paediatr. Jpn. 1998; 40: 286-9.
7. 7 Gross WL, Schmitt WH, Csernok E. ANCA and associated diseases: Immunodiagnostic and pathogenetic aspects. Clin. Exp. Immunol. 1993; 91: 1-12.
8. 8 Jayne DRW, Rasmussen N for the European Community Systemic Vasculitis Clinical Trials Study Group. Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis. Mayo Clin. Proc. 1997; 72: 737-47.
9. 9 Hori Y, Arizono K, Hara S, Kawai R, Hara M, Yamada A. Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis associated with thiamazole therapy. Nephron 1996; 74: 734-5.
10. 10 Haapala AM, Soppi E, Hyöty H, Mustonen J, Pasternack A. Cross-reactivity between antibodies to thyroid microsomal antigens and myeloperoxidase. Lancet 1991; 337: 803.